Back to Search Start Over

IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis.

Authors :
Garnier L
Pick R
Montorfani J
Sun M
Brighouse D
Liaudet N
Kammertoens T
Blankenstein T
Page N
Bernier-Latamani J
Tran NL
Petrova TV
Merkler D
Scheiermann C
Hugues S
Source :
Science advances [Sci Adv] 2022 Jun 10; Vol. 8 (23), pp. eabl5162. Date of Electronic Publication: 2022 Jun 08.
Publication Year :
2022

Abstract

Tumor-associated lymphatic vessels promote metastasis and regulate antitumor immune responses. Here, we assessed the impact of cytotoxic T cells on the local lymphatic vasculature and concomitant tumor dissemination during an antitumor response. Interferon-γ (IFN-γ) released by effector T cells enhanced the expression of immunosuppressive markers by tumor-associated lymphatic endothelial cells (LECs). However, at higher effector T cell densities within the tumor, T cell-based immunotherapies induced LEC apoptosis and decreased tumor lymphatic vessel density. As a consequence, lymphatic flow was impaired, and lymph node metastasis was reduced. Mechanistically, T cell-mediated tumor cell death induced the release of tumor antigens and cross-presentation by tumor LECs, resulting in antigen-specific LEC killing by T cells. When LECs lacked the IFN-γ receptor expression, LEC killing was abrogated, indicating that IFN-γ is indispensable for reducing tumor-associated lymphatic vessel density and drainage. This study provides insight into how cytotoxic T cells modulate tumor lymphatic vessels and may help to improve immunotherapeutic protocols.

Details

Language :
English
ISSN :
2375-2548
Volume :
8
Issue :
23
Database :
MEDLINE
Journal :
Science advances
Publication Type :
Academic Journal
Accession number :
35675399
Full Text :
https://doi.org/10.1126/sciadv.abl5162